Items where Author is "Rugo, H.S."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 2.


Rugo, H.S. and Pennella, E.J. and Gopalakrishnan, U. and Hernandez-Bronchud, M. and Herson, J. and Koch, H.F. and Loganathan, S. and Deodhar, S. and Marwah, A. and Manikhas, A. and Bondarenko, I. and Parra, J.D. and Abesamis-Tiambeng, M.L.T. and Akewanlop, C. and Vynnychenko, I. and Sriuranpong, V. and Roy, S. and Yanez Ruiz, E.P. and Barve, A. and Waller, C.F. (2021) Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial. The Breast, 58. pp. 18-26. ISSN 0960-9776

Rugo, H.S. and Rossi, G. and Rizzi, G. and Borroni, M.E. and Lorusso, V. and Kapthaus, M. and Bondarenko, I. and Sarosiek, T.J. and Aapro, M.S. (2013) NEPA, a fixed-dose combination of netupitant and palonosetron, prevents chemotherapy-induced nausea and vomiting (CINV) more effectively and reduces the impact on daily living for breast cancer patients compared with palonosetron. American Association for Cancer Research, 73 (Sup.24).

This list was generated on Wed Dec 1 02:14:18 2021 EET.